NYU Langone Health
New York, 10016, United States
Location status: Recruiting
NCT Number: NCT05884775
Investigators will conduct a hybrid type 1 effectiveness-implementation randomized controlled trial (RCT) to evaluate the effectiveness of iMatter2 versus usual care on reduction in HbA1c at 12-months (primary outcome) among patients with Type 2 diabetes (T2D).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
New York, 10016, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
PCP Group:
Patient Group:
Exclusion criteria
Patient Group:
Once the program begins, the AI chatbot sends daily text messages that include the PRO questions; a link to a library of educational resources tailored to their responses and personalized motivational messages with support. Participants will also be sent links to the interactive web-based dashboard that visualizes their daily PRO and HbA1c data. PCPs will be able to view reports of patients' PRO and A1c data through the EHR interface, which can be reviewed during visits with the patient or asynchronously to track patient PROs between visits.
Other names: iMatter2
Time frame: Baseline, Month 12
HbA1c will be extracted from lab data available within the EHR
Time frame: Up to Month 14
Time frame: Up to Month 14
Time frame: Up to Month 14
Time frame: Up to Month 14
Time frame: Up to Month 14
Time frame: Up to Month 14
Time frame: Up to Month 14
Time frame: Up to Month 14
Time frame: Up to Month 14
Time frame: Up to Month 14
Time frame: Up to Month 14
Time frame: Up to Month 14
Contact information is provided by the study sponsor or research team.
NYU Langone Health
Other
iMatter2: An Artificial Intelligence (AI)-Driven Approach to Supercharge a Novel Digital Patient-reported Outcomes Tool for Diabetes Management
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07032844
Diabetes Mellitus, Diabetes Mellitus, Type 2
Birmingham, Alabama, United States
View Trial DetailsNCT06067399
Diabetes Mellitus, Diabetes Mellitus, Type 2
Al Khārjah, Egypt
View Trial DetailsNCT07564414
Body Weight, Diabetes Mellitus
Birmingham, Alabama, United States
View Trial DetailsNCT07622628
Diabetes Mellitus, Diabetes Mellitus Type 2
Izmir, Turkey (Türkiye)
View Trial Details